Epsilon M&A Deal Report - Norgine Portfolio of Three OTC Products
Transaction Multiples for the Valuation of Private Companies
Meda / Norgine Portfolio of Three OTC Products
No EMAT :
21980
Announced Date :
11/11/2010
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Meda
Target :
Norgine Portfolio of Three OTC Products
Country :
Netherlands
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
The aquired products from Norgine BV are Pyralvex (relief of pain associated with eg aphthous ulcers), Spasmonal and Waxsol (ear drops). SPASMONAL for the relief of smooth muscle spasm, in...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 03/11/2010 | Wilex | Heidelberg Pharma | Germany | ** | 21959 |
| 01/12/2010 | Dechra Pharmaceuticals | Genitrix | United Kingdom | * | 21955 |
Source: Epsilon Research / EMAT
